These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33478249)

  • 1. Genetic Variation in Enhancers Modifies Cardiomyopathy Gene Expression and Progression.
    Gacita AM; Fullenkamp DE; Ohiri J; Pottinger T; Puckelwartz MJ; Nobrega MA; McNally EM
    Circulation; 2021 Mar; 143(13):1302-1316. PubMed ID: 33478249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incomplete-penetrant hypertrophic cardiomyopathy
    Lee S; Vander Roest AS; Blair CA; Kao K; Bremner SB; Childers MC; Pathak D; Heinrich P; Lee D; Chirikian O; Mohran SE; Roberts B; Smith JE; Jahng JW; Paik DT; Wu JC; Gunawardane RN; Ruppel KM; Mack DL; Pruitt BL; Regnier M; Wu SM; Spudich JA; Bernstein D
    Proc Natl Acad Sci U S A; 2024 May; 121(19):e2318413121. PubMed ID: 38683993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based variation in cardiomyopathy genes.
    Golbus JR; Puckelwartz MJ; Fahrenbach JP; Dellefave-Castillo LM; Wolfgeher D; McNally EM
    Circ Cardiovasc Genet; 2012 Aug; 5(4):391-9. PubMed ID: 22763267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bridging between Mouse and Human Enhancer-Promoter Long-Range Interactions in Neural Stem Cells, to Understand Enhancer Function in Neurodevelopmental Disease.
    D'Aurizio R; Catona O; Pitasi M; Li YE; Ren B; Nicolis SK
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studying Pathogenetic Contribution of a Variant of Unknown Significance, p.M659I (c.1977G > A) in MYH7, to the Development of Hypertrophic Cardiomyopathy Using CRISPR/Cas9-Engineered Isogenic Induced Pluripotent Stem Cells.
    Pavlova SV; Shulgina AE; Zakian SM; Dementyeva EV
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced myofilament calcium sensitivity aggravates abnormal calcium handling and diastolic dysfunction in patient-specific induced pluripotent stem cell-derived cardiomyocytes with MYH7 mutation.
    Guo G; Wang L; Li X; Fu W; Cao J; Zhang J; Liu Y; Liu M; Wang M; Zhao G; Zhao X; Zhou Y; Niu S; Liu G; Zhang Y; Dong J; Tao H; Zhao X
    Cell Calcium; 2024 Jan; 117():102822. PubMed ID: 38101154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplexed Functional Assessments of
    Friedman CE; Fayer S; Pendyala S; Chien WM; Loiben A; Tran L; Chao LS; McKinstry A; Ahmed D; Farris SD; Stempien-Otero A; Jonlin EC; Murry CE; Starita LM; Fowler DM; Yang KC
    Circ Genom Precis Med; 2024 Apr; 17(2):e004377. PubMed ID: 38362799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of sequence determinants of enhancer function using natural genetic variation.
    Yang MG; Ling E; Cowley CJ; Greenberg ME; Vierbuchen T
    Elife; 2022 Aug; 11():. PubMed ID: 36043696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYH7 in cardiomyopathy and skeletal muscle myopathy.
    Gao Y; Peng L; Zhao C
    Mol Cell Biochem; 2024 Feb; 479(2):393-417. PubMed ID: 37079208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel mutations including a double mutation in patients with inherited cardiomyopathy by a targeted sequencing approach using the Ion Torrent PGM system.
    Zhao Y; Cao H; Song Y; Feng Y; Ding X; Pang M; Zhang Y; Zhang H; Ding J; Xia X
    Int J Mol Med; 2016 Jun; 37(6):1511-20. PubMed ID: 27082122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allele-Specific Suppression of Variant MHC With High-Precision RNA Nuclease CRISPR-Cas13d Prevents Hypertrophic Cardiomyopathy.
    Yang P; Lou Y; Geng Z; Guo Z; Wu S; Li Y; Song K; Shi T; Zhang S; Xiong J; Chen AF; Li D; Pu WT; Da L; Zhang Y; Sun K; Zhang B
    Circulation; 2024 Jul; 150(4):283-298. PubMed ID: 38752340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptation and validation of the ACMG/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen's Inherited Cardiomyopathy Expert Panel.
    Kelly MA; Caleshu C; Morales A; Buchan J; Wolf Z; Harrison SM; Cook S; Dillon MW; Garcia J; Haverfield E; Jongbloed JDH; Macaya D; Manrai A; Orland K; Richard G; Spoonamore K; Thomas M; Thomson K; Vincent LM; Walsh R; Watkins H; Whiffin N; Ingles J; van Tintelen JP; Semsarian C; Ware JS; Hershberger R; Funke B
    Genet Med; 2018 Mar; 20(3):351-359. PubMed ID: 29300372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiomyocyte Apoptosis Is Associated with Contractile Dysfunction in Stem Cell Model of
    Loiben AM; Chien WM; Friedman CE; Chao LS; Weber G; Goldstein A; Sniadecki NJ; Murry CE; Yang KC
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myosin inhibitor reverses hypertrophic cardiomyopathy in genotypically diverse pediatric iPSC-cardiomyocytes to mirror variant correction.
    Kinnear C; Said A; Meng G; Zhao Y; Wang EY; Rafatian N; Parmar N; Wei W; Billia F; Simmons CA; Radisic M; Ellis J; Mital S
    Cell Rep Med; 2024 May; 5(5):101520. PubMed ID: 38642550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roadmap to determine the point mutations involved in cardiomyopathy disorder: a Bayesian approach.
    Kumar A; Rajendran V; Sethumadhavan R; Purohit R
    Gene; 2013 Apr; 519(1):34-40. PubMed ID: 23403236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidimensional structure-function relationships in human β-cardiac myosin from population-scale genetic variation.
    Homburger JR; Green EM; Caleshu C; Sunitha MS; Taylor RE; Ruppel KM; Metpally RP; Colan SD; Michels M; Day SM; Olivotto I; Bustamante CD; Dewey FE; Ho CY; Spudich JA; Ashley EA
    Proc Natl Acad Sci U S A; 2016 Jun; 113(24):6701-6. PubMed ID: 27247418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rewiring of 3D Chromatin Topology Orchestrates Transcriptional Reprogramming and the Development of Human Dilated Cardiomyopathy.
    Feng Y; Cai L; Hong W; Zhang C; Tan N; Wang M; Wang C; Liu F; Wang X; Ma J; Gao C; Kumar M; Mo Y; Geng Q; Luo C; Lin Y; Chen H; Wang SY; Watson MJ; Jegga AG; Pedersen RA; Fu JD; Wang ZV; Fan GC; Sadayappan S; Wang Y; Pauklin S; Huang F; Huang W; Jiang L
    Circulation; 2022 May; 145(22):1663-1683. PubMed ID: 35400201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isogenic models of hypertrophic cardiomyopathy unveil differential phenotypes and mechanism-driven therapeutics.
    Bhagwan JR; Mosqueira D; Chairez-Cantu K; Mannhardt I; Bodbin SE; Bakar M; Smith JGW; Denning C
    J Mol Cell Cardiol; 2020 Aug; 145():43-53. PubMed ID: 32531470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic response to environmental stress: Assembly of BRG1-G9a/GLP-DNMT3 repressive chromatin complex on Myh6 promoter in pathologically stressed hearts.
    Han P; Li W; Yang J; Shang C; Lin CH; Cheng W; Hang CT; Cheng HL; Chen CH; Wong J; Xiong Y; Zhao M; Drakos SG; Ghetti A; Li DY; Bernstein D; Chen HS; Quertermous T; Chang CP
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1772-81. PubMed ID: 26952936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional genome architectural CCCTC-binding factor makes choice in duplicated enhancers at Pcdhα locus.
    Wu Y; Jia Z; Ge X; Wu Q
    Sci China Life Sci; 2020 Jun; 63(6):835-844. PubMed ID: 32249388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.